Skip to main content
HR 2376 115th Congress House Health Consumer affairs Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Fraud offenses and financial crimes Manufacturing

Drug Diversion and Counterfeit Crackdown Act of 2017

Introduced: May 4, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 5, 2017
Referred to the Subcommittee on Health.
May 4, 2017
Referred to the House Committee on Energy and Commerce.
May 4, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Drug Diversion and Counterfeit Crackdown Act of 2017

This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.

The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.

What's happening now May 5, 2017

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • HR 2430 Related bill FDA Reauthorization Act of 2017
  • S 934 Related bill FDA Reauthorization Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Dingell, Debbie
Michigan · May 4, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2376: Drug Diversion and Counterfeit Crackdown Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2376/
MLA
"H.R. 2376: Drug Diversion and Counterfeit Crackdown Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2376/.
Bluebook (legal)
H.R. 2376, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2376/.
Markdown link
[H.R. 2376: Drug Diversion and Counterfeit Crackdown Act of 2017](https://openamerica.io/bill/115-HR-2376/)
Report a problem